Board Member
Becton Dickinson & Co (BDX)Equibles does not estimate personal net worth.
Get an email with a short summary when Becton Dickinson & Co publishes a filing, an earnings call transcript or a press release.
Get BDX alertsThomas Polen is recorded as Board Member at Becton Dickinson & Co (BDX) since January 1, 2020 and CEO at Becton Dickinson & Co (BDX). Thomas Polen has spoken on 4 earnings calls across 1 company, most recently for Becton Dickinson & Co on November 6, 2025. Becton Dickinson & Co is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Becton Dickinson & Co includes David F. Melcher (Chairman), Thomas E. Polen (Chairman and Board Member), Patrick K. Kaltenbach (CTO) and 7 others.
“As you saw in our press release, our Q4 and full year performance was in line with the preliminary results we announced last month. During our prepared remarks today, Chris and I will provide additional context on the drivers of our performance.”
“I'm extremely proud of our organization and our performance this year. We closed the year with excellent momentum, having delivered strong and consistent growth in our base business.”
“We're very happy to have you on the team. Good morning, everyone, and thank you for joining us. We are very pleased with our strong performance in Q1. It reflects the continued execution of our BD2025 strategy and another quarter of consistent strong growth in our base business.”
“We are very pleased with our Q1 results, which were ahead of our expectations, reflecting the tremendous efforts and execution of BD’s 70,000 associates. The essential role of our products and solutions in healthcare and the greater resiliency of the health care system in treating both COVID and non-COVID patients.”
2020-01-01–present
Medical Instruments & Supplies · Healthcare
CEO, Board Member
2020-01-01–present
